Could a 15-Day pill stop breast cancer before it starts?
Disease control
Completed
This study tested whether the drug ruxolitinib can reduce abnormal cells in people with high-risk breast conditions like atypical hyperplasia or ductal carcinoma in situ (DCIS). Half of the 84 participants took ruxolitinib for about 15 days before surgery, while the other half to…
Phase: PHASE2 • Sponsor: Julie Nangia • Aim: Disease control
Last updated May 04, 2026 16:24 UTC